NEUROLEPTIC MALIGNANT SYNDROME

被引:0
作者
MIGNOT, G
机构
来源
THERAPIE | 1986年 / 41卷 / 01期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:63 / 67
页数:5
相关论文
共 56 条
[1]  
ALLEN RC, 1972, BR MED J, V1, P121
[2]  
AQUARON R, 1984, THERAPIE, V39, P29
[3]  
AZORIN JM, 1984, PRESSE MED, V13, P1702
[4]  
BENOIT P, 1981, CONCOURS MED, V103, P1063
[5]  
BERNSTEIN RA, 1979, PSYCHOSOMATICS, V20, P840
[6]  
Bourgeois M, 1971, Ann Med Psychol (Paris), V2, P729
[7]  
BRITT BA, 1979, FED PROC, V38, P44
[8]   MALIGNANT HYPERTHERMIA - A STATISTICAL REVIEW [J].
BRITT, BA ;
KALOW, W .
CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1970, 17 (04) :293-+
[9]   POSSIBLE RECEPTOR EFFECTS OF CHRONIC LITHIUM ADMINISTRATION [J].
BUNNEY, WE ;
GARLAND, BL .
NEUROPHARMACOLOGY, 1983, 22 :367-372
[10]   NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].
BURKE, RE ;
FAHN, S ;
MAYEUX, R ;
WEINBERG, H ;
LOUIS, K ;
WILLNER, JH .
NEUROLOGY, 1981, 31 (08) :1022-1026